Liver neo-tissue suitable for transplantation has not been established. Primary rat hepatocytes were cultured on three-dimensional biodegradable polymer matrices in a pulsatile flow bioreactor with the intention of inducing tissue formation and improving cell survival. Functional and structural analysis of the hepatocytes forming liver neo-tissue was performed. Biodegradable poly(L-lactic acid) (PLLA) polymer discs were seeded with 4 Â 10 6 primary rat hepatocytes each, were exposed to a pulsatile medium flow of 24 mL/min for 1, 2, 4, or 6 days and were investigated for monoethylglycinexylidine (MEGX) formation, ammonia detoxification, Cytokeratin 18 (CK18) expression, and preserved glycogen storage. Fine structural details were obtained using scanning and transmission electron microscopy. Spheroids of viable hepatocytes were formed. MEGX-specific production was maintained and ammonia removal capacity remained high during the entire flow-culture period of 6 days. CK18 distribution was normal. Periodicacid-Schiff reaction demonstrated homogenous glycogen storage. The hepatocytes reassembled to form intercellular junctions and bile canaliculi. Functional and morphological analysis of rat hepatocytes forming spheroids in a pulsatile flow bioreactor indicated preserved and intact hepatocyte morphology and specific function. Pulsatile flow culture on PLLA scaffolds is a promising new method of hepatic tissue engineering leading to liver neo-tissue formation.
INTRODUCTION T
HE LIVER HAS AN IMPRESSIVE REGENERATIVE POTENTIAL, as we know from clinical and experimental observations.
1,2 Approximately 15-25% of patients with acute liver failure have a chance for spontaneous recovery. 3 In modern liver surgery, up to 70% of the liver can be resected and will grow back to the original size within months. 4, 5 The excellent regenerative potential of liver cells has been the motivation for numerous researchers to focus on hepatocyte transplantation in the last decades. Next to liver transplantation, the transplantation of a sufficient number of hepatocytes may offer a valuable therapeutical approach for patients with liver-based metabolic defects and for patients with fulminant hepatic failure.
Vacanti and Langer proposed a strategy to deliver hepatocytes into the recipient using biodegradable polymers as a scaffold, 6, 7 thereby applying the principles and methods of tissue engineering. [8] [9] [10] This method allows the transplantation of a large cell volume after seeding on a polymer scaffold. 11 Highly porous polymer scaffolds provide sufficient space and protection for the hepatocytes to attach and permit oxygenation. Their three-dimensional structure helps the hepatocytes to reorganize into a configuration similar to their native environment and would allow vascular ingrowth. The scaffold is needed only during the initial period of tissue formation. Thereafter the polymer degrades via hydrolysis. 12 Many investigators have observed spheroidal formation of cultured hepatocytes, which is thought to be advantageous for several reasons. Such aggregated hepatocytes have proven to have better resistance to chemical and radiation stress and have shown higher levels of differentiated metabolic functions than monolayer hepatocyte cultures. [13] [14] [15] [16] [17] [18] [19] We adapted a hepatocyte transplantation model using hepatocytes seeded onto a biodegradable polymer matrix. [20] [21] [22] To improve survival and function of hepatocytes under shear stress conditions similar to an in vivo setting, we induced the formation of spheroidal aggregates (spheroids) in a pulsatile flow bioreactor. [23] [24] [25] Our hypothesis was that flow bioreactor culture conditions for hepatocytes on biodegradable polymer matrices would improve hepatocyte survival and metabolic function after transplantation. In the present study we analyzed the functional and morphological characteristics of spheroid-forming hepatocytes. For this purpose, specific enzyme function analysis such as ammonia removal and monoethylglycinexylidide (MEGX) formation, Cytokeratin 18 (CK18) immunohistochemistry, and Periodic-acid-Schiff (PAS) staining, as well as scanning and transmission electron microscopy, were used.
MATERIALS AND METHODS

Polymer fabrication
Poly(L-lactic acid) (PLLA) polymer discs with 95% porosity were fabricated as previously described. 24, 26, 27 Polymers were manufactured to dimensions of 18 mm diameter and 1 mm thickness, with a pore size of 200 to 400 mm, and then cold-gas sterilized with ethylene oxide (H.W. Anderson Products, Chapel Hill, NC) before use.
Hepatocyte isolation
Adult, male, in-bred Lewis rats weighing between 200 and 300 g were used in all experiments (Charles River, Sulzfeld, Germany). The animals were housed in the Animal Research Facility of the University Medical Center Hamburg-Eppendorf, Germany, in accordance with the German national guidelines for the care of laboratory animals (Deutsches Tierschutzgesetz). Animals were given access to rat chow (Altromin Standard, Altromin, Hamburg, Germany) and water ad libitum and were maintained in 12-h light/dark cycles. Hepatocytes were isolated using a twostep collagenase digestion as previously described, using the original method of Seglen 28 and modification of Aiken et al. 29 The extracellular matrix was digested using a 0.025% collagenase solution (Collagenase type 2, Worthington, CellSystems Biotechnologie, St. Katharinen, Germany). Hepatocyte number and viability were determined using trypan blue exclusion.
Polymer seeding
Polymers were homogeneously seeded with 400 mL of hepatocyte suspension containing 4 Â 10 6 cells. The entire seeding procedure was performed on ice. We allowed the hepatocytes to attach for 20 min.
Culture medium
Hepatocytes on polymer constructs were cultured in serumfree Williams' Medium E without L-glutamine (Gibco BRL) supplemented with 2 mM N-acetyl-L-alanyl-L-glutamine (Biochrom, Berlin, Germany), 20 mM HEPES buffer (Biochrom), 4 mg/mL insulin (Gibco BRL), 1 mM sodium pyruvate (Gibco BRL), 5 nM dexamethasone (Sigma, St. Louis, MO), 10 ng/mL epidermal growth factor (Gibco BRL), and 1% penicillin/streptomycin (Biochrom).
Culture conditions
Polymer constructs (n ¼ 32) with hepatocytes were secured perpendicular to the flow vector in a modified Cellmax Quad system (Cellco, Germantown, MD) as previously described. 23 One construct each per culture system was exposed to 24 mL/min of pulsatile flow. Culture medium was pumped from a 265 mL reservoir using a Cellmax Quad pump apparatus (Cellco). Medium was recirculated back to the reservoir after passing through the culture chamber. The silicon tubing connecting the culture chamber with the medium reservoir allowed for gas exchange. All cultures were performed at 378C with 5% carbon dioxide supplementation inside an incubator. The tissue engineered cellpolymer constructs were harvested after 1, 2, 4, or 6 days in culture.
Specimen analysis
After stopping the medium flow, cell-polymer constructs were removed from the flow chamber of the bioreactor and transferred into polystyrene culture dishes for viewing by phase-contrast microscopy (Olympus IX 50, Hamburg, Germany) before further investigation or fixation. Culture medium was sampled for analysis.
Lidocaine-MEGX test
At the end of each culture period the hepatocyte-polymer specimens were cut in half, transferred onto a culture dish, and incubated with 3 mL of a 0.24 mg/mL (w/v) solution of lidocaine/supplemented Williams' E culture medium at 378C for 30 min. The quantity of MEGX was measured using a TDxFLx fluorescencepolarization system using a MEGX assay (Abbott Laboratories, Abbott Park, IL).
Ammonia removal
At the end of the culture period the hepatocyte-polymer constructs were cut in half, transferred to a culture dish, and incubated with 10 mL supplemented Williams' Medium E additionally containing 0.5 mM ammonium chloride. After incubation at 378C for 2 and 4 h, the ammonia concentration in the medium was measured using an indophenol method (Ammonia, Wako Chemicals, Neuss, Germany). The color reaction was measured at 630 nm using spectrophotometry (UV-160A Spectrophotometer, Shimadzu, Duisburg).
30,31
CK18 immunohistochemistry
Immunohistochemical staining to demonstrate CK18 was performed on cryopreserved sections (6 mm) of the hepatocyte spheroid specimens using the ABC method (Vectastain ABC-Kit, Vector, Burlingame, Canada). Specimens were fixed in acetone at -208C for 4 min. A mouse anti-human anti-CK18 immunoglobulin G (IgG) antibody was used as primary antibody (1:50) (Progen, Heidelberg, Germany), with incubation for 60 min at room temperature. Biotinylated anti-mouse IgG was used as secondary antibody (1:200), with incubation for 30 min at room temperature (Vector). After each step of the immunohistochemical reaction, three 2-min washing steps in phosphate buffered saline, pH 7.4, were performed. Sections were counterstained with hematoxylin and mounted.
PAS reaction
PAS reaction was applied as described previously 32 to demonstrate glycogen content of rat hepatocyte-forming spheroids at every time point during the culture period. The intensity of the PAS reaction of the cultured hepatocytes forming spheroids was compared with standard rat liver sections.
Scanning and transmission electron microscopy
For scanning and transmission electron microscopy, the polymer-spheroid specimens were fixed at 48C in 3% glutaraldehyde in 0.1 M phosphate buffer. Specimens were washed with 0.1 M phosphate-saccharose overnight and postfixed with 1% osmium tetroxide in 0.1 M phosphatesaccharose. Specimens were dehydrated through graded series (35-100%) of ethanol.
For scanning electron microscopy, prepared specimens were dried using a critical point dryer and placed on mounting studs. The mounted specimens were coated with gold on a sputter coater (BioRad, SEM Coating System, Richmond, CA). The coated specimens were stored in a desiccator until time of viewing under the scanning electron microscope (Zeiss DSM 940, Oberkochen, Germany).
For transmission electron microscopy, to extract the hepatocyte spheroids from the polymer scaffold, the following procedure was performed. The prepared specimens were incubated twice for 10 min in propylene oxide at 48C, followed by 5 min centrifugation at 1500 rpm; then the supernatant was removed. The pellet was incubated for 1 h in a 1:1 (v/v) mixture of Epon (Serva, Heidelberg, Germany) and propylene oxide, followed by centrifugation. This procedure was repeated using an incubation in 1:3 (v/v) Epon/ propylene oxide and then in 100% Epon and subsequently polymerized for 24 h at 608C. The polymerized samples underwent ultrathin sectioning with Ultracut E (ReichertJung, Heidelberg, Germany), were stained with uranyl acetate and lead citrate, and were then viewed under a transmission electron microscope (Philips CM 100, Kassel, Germany).
RESULTS
Spheroid formation in flow bioreactor
Freshly isolated primary rat hepatocytes with a viability of more than 85% were seeded on highly porous polymer scaffolds and cultured in a pulsatile flow bioreactor. After 1, 2, 4, or 6 days, the hepatocyte-polymer constructs were removed from the culture system and analyzed under phasecontrast microscopy. Already after 1 day, hepatocytes formed tightly packed cellular aggregates with smooth boundaries. These spherical-shaped aggregates, called spheroids, had a diameter ranging from 50 to 300 mm. 25 
Lidocaine-MEGX test
Cytochrome P450, usually present in hepatocytes, catalyzes the biotransformation of a wide variety of xenobiotics. 33 The P450 enzyme activity of hepatocyte spheroids cultured in a flow bioreactor was determined in vitro by their ability to transform lidocaine to its metabolite MEGX. This test measures the activity of the most important P450 isoenzyme, CYP3A2, as well as CYP2B1. Lidocaine was exogenously added, and its degradation to the metabolic product, MEGX, was measured. The MEGX production would correlate with the metabolic activity of the hepatocytes in spheroids. Indeed, MEGX production was maintained at relatively constant rates during the 6 days of flow culture and varied between 14.28 AE 2.86 ng/mL/30 min and 23.13 AE 4.63 ng/mL/30 min (Fig. 1) 
Ammonia removal
Ammonia metabolism is an important differentiated metabolic function of hepatocytes. To evaluate the ammonia detoxification capacity of the hepatocyte spheroids, hepatocyte-polymer specimens were exposed to exogenous ammonia after they were removed from the bioreactor. The elimination rate of ammonia from the culture medium was determined after 2 and 4 h of incubation. The reduction in ammonia concentration within the first 4 h of exposure approximately doubled the rate after 2 h with the two curves running parallel (Fig. 2) 
CK18 immunohistochemistry
Cytokeratins are the most complex group within the intermediate filaments (7-11 nm in diameter) of the cytoskeleton. 34 Hepatocytes contain CK18. Immunohistochemical staining with anti-CK18 antibody demonstrated a strong signal for CK18 in the spheroid-forming hepatocytes during the entire culture period of 6 days (Fig. 3) .
PAS staining
PAS staining revealed preserved glycogen storage in rat hepatocytes forming spheroids in the flow bioreactor at every observation time point. Purple reactions of similar intensity could be observed at Day 1, 2, 4, and 6. This corresponded with the color reaction of control rat liver section (Fig. 4) .
Scanning and transmission electron microscopy
Scanning electron microscopy of spheroids under threedimensional culture conditions showed them within or adjacent to the cubical chambers of the PLLA scaffold (Fig. 5) . At higher magnification, the borders of individual hepatocytes and fine microvilli on their surface were recognizable. Holes and slits between hepatocytes on the surface of spheroids were found especially at the contact points of three hepatocytes.
Transmission electron microscopy of hepatocyte spheroids up to 6 days in flow culture revealed that the cellular elements of spheroidal aggregates showed the typical fine-structural characteristics of polarized and aggregated hepatocytes, including the formation of bile canaliculi with mature junctional complexes on both sides and lined by numerous microvilli (Fig. 6 ).
DISCUSSION
The scarcity of donor organs has become the biggest problem of liver transplantation worldwide. According to the Eurotransplant and United Network for Organ Sharingregistries, the number of newly registered patients is increasing every year. Although alternative transplantation methods such as living-related transplantation, 35, 36 or split liver transplantation, 37, 38 are increasingly applied, 363 patients died in 2002 in the Eurotransplant region while waiting for a liver transplant. Only 1263 liver transplants could be performed. 39 The situation is similar in the United States. According to the Organ Procurement and Transplantation Network/Scientific Registry of Transplant Recipients 2003 Annual Report, 1818 patients died while waiting for a donor liver in 2002. The number of patients on the waiting list at the end of 2002 was 16,974, which represents an almost 6-fold increase over a period of ten years. 40 Transplantation of hepatocytes may offer a valuable therapeutic approach for patients with liver-based metabolic defects and for patients with fulminant hepatic failure. Hepatocyte transplantation has the advantage over liver transplantation that the liver of the recipient remains in situ. In the case of the disease being a metabolic defect, the native liver continues to perform most of its functions. In the case of transient hepatic failure, the damaged liver may regain all its functions so that the transplanted hepatocytes are not permanently needed. Several problems of liver transplantation, such as vascular and biliary complications, or the side effects of long-term immunosuppressive medication could thereby be avoided. More patients could receive a treatment adapted to their particular liver disease by making better use of the available donor tissue or using part of their own liver as a cell source for the treatment of hepatocyte-based metabolic disorders after ex vivo gene therapy of their hepatocytes. A further promising cell-based treatment modality for liver failure and metabolic diseases is the administration of stem cells with in vivo or in vitro differentiation into metabolically active hepatocytes. If necessary, the option to perform a liver transplantation remains open. Hepatocyte transplantation could also complement liver transplantation, bridging the time until a suitable donor organ is available for a patient with acute liver failure.
Several methods to deliver hepatocytes into a recipient have been developed. Hepatocytes were injected into the splanchnic system (portal vein or spleen) or into various tissues or body cavities (dorsal fascia, peritoneum, omentum, pleural cavity). [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] In a second approach, the hepatocytes were attached to microcarriers or larger polymer scaffolds. 6, 11, 23, 52, 53 The optimal method to transplant hepatocytes has not been defined. A critical step of hepatocyte transplantation remains the engraftment of sufficient cell mass to achieve metabolic replacement. The major problem of the injection method is the restriction of the number of transplantable hepatocytes to approximately 5% of liver mass, because otherwise one runs the risk of inducing portal venous embolism or host tissue necrosis. Attachment of the hepatocytes to implantable scaffolds allows the number of transplantable hepatocytes to be increased up to a number of hepatocytes equivalent to the whole liver mass. 11 The hepatocytes can be transplanted into vascularized areas of the body within a polymer scaffold and supplied with hepatotrophic factors from the portal circulation. [20] [21] [22] 54, 55 The drawback of this method is the high initial cell loss directly after transplantation. 56 Our laboratory and others have investigated heterotopic hepatocyte transplantation on biodegradable polymer matrices as an experimental treatment for liver diseases. 6, 8, 57, 58 It could be demonstrated that the surviving hepatocytes, transplanted on a polymer scaffold, can regenerate in situ up to 10-fold. 21 Applying in vitro methods of tissue engineering may provide a valuable tool to improve the matrix-attached hepatocyte or liver neo-tissue transplantation method. Conditioning the hepatocytes in three-dimensional culture within the polymer-matrix before implantation may result in better survival and functional status of the cells after transplantation.
Three-dimensional culture models could be beneficial for hepatocyte survival and preserved morphology and function. Hepatocyte morphology can be maintained by sandwiching the cells between two hydrated collagen layers 59 or by stimulating them to form spheroidal aggregates. [16] [17] [18] [19] 60, 61 It was proven that the extracellular matrix can regulate proliferation and differentiated functions of cultured hepatocytes. 62, 63 A critical test for the viability of hepatocytes in culture is the maintenance of good oxygen supply, as well as nutrition and waste removal. 55, 64 Consideration of these criteria led us to develop a pretransplantation culture system for hepatocytes, to come the closest to ideal hepatocyte transplantation conditions.
In a previous in vitro study, we were able to demonstrate spheroid formation of primary rat hepatocytes in a pulsatile flow bioreactor system with hepatocyte culture on a three-dimensional polymer scaffold 23 and to optimize the pre-transplantation culture conditions of hepatocyte spheroids. 24, 25 In the pulsatile flow bioreactor culture, primary rat hepatocytes preserved viability, morphology, and differentiated function as demonstrated by functional and structural analysis. We presume that the formation of spheroids is an advantageous configuration in improving the posttransplantation viability of hepatocytes. Generation of spheroids in static culture systems takes 3 to 7 days, 14, 60, [65] [66] [67] [68] [69] [70] [71] although with dynamic culture systems, it takes only 1 to 2 days. 15, 23, [72] [73] [74] [75] [76] [77] [78] Our culture system, using pulsatile flow of culture medium, imitates the physiologic situation of blood flow in the organism. 23, 75 With this special culture system, we achieved the formation of spheroidal hepatocyte aggregates within the first 24 h. The vast majority (94%) of spheroids were less than 200 mm in diameter, and therefore, sufficient oxygen and nutrient supply was granted 25 even to the cells in the center of the spheroids. 79 We previously found that primary rat hepatocytes forming spheroids in a pulsatile flow bioreactor system consisted of viable hepatocytes, expressed active metabolic function, and preserved albumin production up to 6 days in culture. 24, 25 The purpose of our study was to analyze the specific functional and morphological characteristics of primary rat hepatocytes forming spheroids in more detail.
The liver is responsible for the vast majority of detoxification of foreign compounds. Lidocaine is an important marker of drug metabolism as a model substrate of phase 1 (oxidation, reduction, hydrolysis) metabolism and as a clinical index to estimate hepatic metabolic reserve capacity. Biotransformation of lidocaine requires cytochrome P450 enzyme function. 33, 70 Our results on MEGX formation as a result of lidocaine metabolism demonstrate that cytochrome P450 enzyme (CYP3A2, CYP2B1) function was preserved during the entire culture period. MEGX production, as an indicator of metabolically active hepatocytes in spheroids, ranged from 1.03 AE 0.21 mg/d/10 6 cells to 1.66 AE 0.33 mg/d/10 6 cells. These levels are in accordance with data (1.2 mg/d/10 6 cells) from other investigators. 80 Ammonia detoxification takes place in the mammalian liver and thus signals intact hepatocyte function. 31 We can conclude from our results that the ammonia detoxification, as a standard test for intact liver function, was maintained in primary rat hepatocytes forming spheroids in flow bioreactor culture during the entire culture period of 6 days. The comparison with previously reported data is difficult because of the diverse culture conditions and variability in the performance of the test. Nevertheless, the ammonia removal of our flow-cultured hepatocyte spheroids (0. CK18 can be found in many diverse simple epithelia. 34, 81, 82, 83 We found that the specific expression distribution of CK18 in the flow bioreactor-cultured hepatocytes was similar to normal rat liver tissue.
Glycogen storage in the hepatocytes plays a central role in glucose and energy metabolism of the organism. The positive PAS staining of the flow-cultured hepatocytes demonstrates their preserved ability to continue to specifically regulate glucose uptake and intracellular metabolism.
Scanning electron microscopy demonstrated spheroidalshaped cell aggregates covered by multiple microvilli on the surface, as a sign of metabolic and functional activity within the pores of the PLLA polymer scaffolds.
Transmission electron microscopy evaluation of the hepatocyte spheroids revealed that they were built up by aggregated hepatocyte-like cells joined by cell junctions. The cells were typically polarized to form bile canaliculi with their apical microvilli-bearing cell surface. The canaliculi were sealed off by tight junctions and were partially open to the surface of the spheroids. Such maintenance of polarized hepatocyte morphology had already been observed in spheroids of rat and porcine hepatocytes 80, 84 and in rat hepatocytes grown on collagen-coated polystyrene beads. 85 In addition, the cells displayed coated pits and vesicles as a sign of receptor-mediated active micropinocytosisevidence of a specifically functioning vesicular transport mechanism.
One of the primary goals of tissue engineering is the maintenance of a high degree of cell viability and cellspecific function within the neo-tissue construct at time of implantation. In this study, we demonstrated that hepatocytes cultured on a biodegradable, highly porous PLLA polymer scaffold under pulsatile flow conditions maintained a high degree not only of viability, but also of hepatocytespecific functions, such as ammonia removal and cytochrome P450-dependent metabolism. The cells display normal distribution of the hepatocyte-specific cytoskeleton component CK18. The glucagon and energy metabolism remains intact, as demonstrated by positive PAS staining.
The primary hepatocytes reassemble in flow culture to form spheroidal organoids, and the cells reassume normal intercellular attachment and communication, including the formation of bile canaliculi between the apical membranes of adjacent cells.
Therefore, pre-cultivation of hepatocytes on a polymer scaffold with induction of metabolically active liver neotissue before implantation may offer an improvement for matrix-based hepatocyte transplantation. Unlike other spheroid-inducing culture systems, the hepatocyte spheroids are already cultured on their implantation vector (polymer scaffold), and no dissociation step is mandatory before implantation.
Our culture system could not only lead toward clinical application of a matrix-based liver neo-tissue implant, but could also serve as a three-dimensional culture model for applications in virology, toxicology, and drug development, in which metabolically active liver organoids could be more advantageous than monolayer hepatocyte cultures.
